4.65% | % of shares held by all insiders |
91.48% | % of shares held by institutions |
95.93% | % of float held by institutions |
195 | Number of institutions holding shares |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
Decheng Capital LLC | 7,083,288 | 30 Dec 2023 | 10.81% | 457,297,055 |
RA Capital Management, L.P. | 4,909,763 | 30 Dec 2023 | 7.49% | 316,974,287 |
Lynx1 Capital Management Lp | 3,813,926 | 30 Dec 2023 | 5.82% | 246,227,053 |
Great Point Partners LLC | 3,703,433 | 30 Dec 2023 | 5.65% | 239,093,625 |
Paradigm Biocapital Advisors LP | 3,176,743 | 30 Dec 2023 | 4.85% | 205,090,520 |
Frazier Life Sciences Management, L.P. | 3,131,008 | 30 Dec 2023 | 4.78% | 202,137,868 |
Blackrock Inc. | 3,058,498 | 30 Dec 2023 | 4.67% | 197,456,623 |
Cormorant Asset Management, LP | 2,550,000 | 30 Dec 2023 | 3.89% | 164,627,993 |
Orbimed Advisors LLC. | 2,535,245 | 30 Dec 2023 | 3.87% | 163,675,411 |
Vanguard Group Inc | 2,234,767 | 30 Dec 2023 | 3.41% | 144,276,552 |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
Vanguard Total Stock Market Index Fund | 1,271,329 | 30 Dec 2023 | 1.94% | 82,076,997 |
Price (T.Rowe) New Horizons Fund | 1,105,737 | 30 Dec 2023 | 1.69% | 71,386,378 |
iShares Russell 2000 ETF | 788,411 | 28 Feb 2024 | 1.20% | 50,899,812 |
SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 753,402 | 28 Feb 2024 | 1.15% | 48,639,631 |
Vanguard Extended Market Index Fund | 573,075 | 30 Dec 2023 | 0.87% | 36,997,720 |
Franklin Strategic Series-Franklin Biotechnology Discove | 387,374 | 30 Jan 2024 | 0.59% | 25,008,864 |
Fidelity Small Cap Index Fund | 329,533 | 30 Jan 2024 | 0.50% | 21,274,649 |
iShares Biotechnology ETF | 278,829 | 28 Feb 2024 | 0.43% | 18,001,199 |
TIAA-CREF Funds-Quant Small Cap Equity Fund | 249,330 | 30 Jan 2024 | 0.38% | 16,096,744 |
Direxion Shares ETF Tr-Direxion Daily S&P Biotech Bull 3x Sh | 234,625 | 30 Mar 2024 | 0.36% | 15,147,389 |